PMP incorporated elevated MMP-2 and MMP-9 protein levels in all three CRC cell lines, and SB202190 reduced the PMP-stimulated levels of MMP-2 and MMP-9 and related invasiveness in these cells. This evidence concerns the gene MMP9 and colorectal carcinoma.